Inhaled medicines: past, present, and future

S Anderson, P Atkins, P Bäckman, D Cipolla… - Pharmacological …, 2022 - Elsevier
The purpose of this review is to summarize essential pharmacological, pharmaceutical, and
clinical aspects in the field of orally inhaled therapies that may help scientists seeking to …

Fungal-bacterial interactions in health and disease

W Krüger, S Vielreicher, M Kapitan, ID Jacobsen… - Pathogens, 2019 - mdpi.com
Fungi and bacteria encounter each other in various niches of the human body. There, they
interact directly with one another or indirectly via the host response. In both cases …

Nebulised hypertonic saline for cystic fibrosis

P Wark, VM McDonald, S Smith - Cochrane Database of …, 2023 - cochranelibrary.com
Background Hypertonic saline enhances mucociliary clearance and may lessen the
destructive inflammatory process in the airways. This is an update of a previously published …

Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence

JC Davies - Paediatric respiratory reviews, 2002 - Elsevier
Pseudomonas aeruginosa is the major pathogen in the cystic fibrosis (CF) lung. Prevalence
is high and, once acquired, chronic infection will almost always ensue. Several hypotheses …

Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial

D Bilton, G Tino, AF Barker, DC Chambers, A De Soyza… - Thorax, 2014 - thorax.bmj.com
Rationale Bronchiectasis is characterised by excessive production of mucus and pulmonary
exacerbations. Inhaled osmotic agents may enhance mucociliary clearance, but few long …

The CF salt controversy: in vivo observations and therapeutic approaches

R Tarran, BR Grubb, D Parsons, M Picher, AJ Hirsh… - Molecular cell, 2001 - cell.com
There is controversy over whether abnormalities in the salt concentration or volume of
airway surface liquid (ASL) initiate cystic fibrosis (CF) airway disease. In vivo studies of CF …

Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis

A Mandelberg, G Tal, M Witzling, E Someck, S Houri… - Chest, 2003 - Elsevier
Objective: To determine the utility of inhaled hypertonic saline solution to treat infants
hospitalized with viral bronchiolitis. Design: Randomized, double-blind, controlled trial. Fifty …

Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines

DC Bolser - Chest, 2006 - Elsevier
Background: Cough-suppressant therapy, previously termed nonspecific antitussive therapy,
incorporates the use of pharmacologic agents with mucolytic effects and/or inhibitory effects …

Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms

EM Sarrell, G Tal, M Witzling, E Someck, S Houri… - Chest, 2002 - Elsevier
Objective To determine the utility of inhaled hypertonic saline solution to treat ambulatory
infants with viral bronchiolitis. Design Randomized, double-blind, controlled trial. Sixty-five …

[CITAZIONE][C] New concepts of the pathogenesis of cystic fibrosis lung disease

RC Boucher - European Respiratory Journal, 2004 - Eur Respiratory Soc